Thursday, July 29, 2021 1:28:33 AM
On June 29, 2021, Relief announced that it had signed and closed the definitive agreement to acquire all outstanding shares of APR Applied Pharma Research S.A., a privately held Swiss biopharmaceutical company with over 25 years’ experience in identifying, developing and commercializing known molecules engineered with drug delivery systems in niche and rare diseases on a global basis.
The acquisition further diversifies Relief's pipeline with both commercial products and clinical-stage programs and provides the initial commercial infrastructure to support future product launches. APR brings to Relief a vibrant R&D organization possessing a lengthy track record of expertise in drug innovation, reformulation and optimization. APR also has a well-respected contract research business, further reflecting the strong R&D capabilities of the APR team and providing Relief additional revenue growth potential.
https://www.relieftherapeutics.com/apr
~ Money Making Money ~
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM